Revvity | PKI - Interest Income


Revvity reported $5.75M in Interest Income for its fiscal quarter ending in December of 2025.





Interest Income Change Date
Agilent USD 15M 2M Dec/2025
Align Technology USD 4.62M 1.37M Dec/2025
Bio Techne USD 897K 74K Dec/2025
Bio-Rad Laboratories USD 31M 17.3M Dec/2025
Bruker USD 4.4M 1.5M Sep/2025
Celltrion KRW 621.35M 55.31M Dec/2025
Charles River Laboratories USD -0.3 1.02M Mar/2026
Danaher USD 27M 14M Mar/2026
Dentsply International USD 4M 1000K Mar/2025
Dianthus Therapeutics USD 3.66M 255K Sep/2025
Edwards Lifesciences USD 56.3M 17.7M Dec/2025
Illumina USD 0.87 10M Mar/2026
Intuitive Surgical USD 91.3M 4.2M Dec/2025
IQVIA Holdings USD 10M 1000K Mar/2026
Kangmei Pharma CNY 2.44M 635.78K Mar/2026
Knight Therapeutics CAD 2.46M 498K Sep/2024
Laboratorios Farma EUR 139K 42K Jun/2025
Medical Developments International AUD 174K 31K Dec/2024
Myriad Genetics USD 300K 0 Mar/2025
Pharma Mar EUR 1.63M 3.17M Dec/2025
Qiagen NV USD 20M 4.93M Dec/2025
Quest Diagnostics USD 2M 1000K Mar/2026
Quidel USD -1.35 500K Mar/2026
Repligen USD 7.31M 979K Mar/2025
Revvity USD 5.75M 5.75M Dec/2025
Sartorius EUR -31.8M 86.7M Dec/2025
Thermo Fisher Scientific USD 258M 258M Dec/2025
Tilray USD 12.83M 20.19M May/2024
Waters USD 5.67M 5.67M Dec/2025
Zhangzhou Pientzehuang Pharmaceutical CNY 2.73M 3.92M Mar/2026